Pastan I - Search Results

1

Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma.

Alewine C, Ahmad M, Peer CJ, Hu ZI, Lee MJ, Yuno A, Kindrick JD, Thomas A, Steinberg SM, Trepel JB, Figg WD, Hassan R, Pastan I. Alewine C, et al. Among authors: pastan i. Clin Cancer Res. 2020 Feb 15;26(4):828-836. doi: 10.1158/1078-0432.CCR-19-2586. Epub 2019 Dec 2. Clin Cancer Res. 2020. PMID: 31792036 Free PMC article. Clinical Trial.

2

Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.

Salvatore G, Beers R, Margulies I, Kreitman RJ, Pastan I. Salvatore G, et al. Among authors: pastan i. Clin Cancer Res. 2002 Apr;8(4):995-1002. Clin Cancer Res. 2002. PMID: 11948105

3

Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.

Nagata S, Onda M, Numata Y, Santora K, Beers R, Kreitman RJ, Pastan I. Nagata S, et al. Among authors: pastan i. Clin Cancer Res. 2002 Jul;8(7):2345-55. Clin Cancer Res. 2002. PMID: 12114439

4

Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.

Hassan R, Lerner MR, Benbrook D, Lightfoot SA, Brackett DJ, Wang QC, Pastan I. Hassan R, et al. Among authors: pastan i. Clin Cancer Res. 2002 Nov;8(11):3520-6. Clin Cancer Res. 2002. PMID: 12429643

5

Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1.

Hassan R, Williams-Gould J, Watson T, Pai-Scherf L, Pastan I. Hassan R, et al. Among authors: pastan i. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):16-8. doi: 10.1158/1078-0432.ccr-1160-3. Clin Cancer Res. 2004. PMID: 14734446 Clinical Trial.

6

Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotin.

Yao Z, Zhang M, Garmestani K, Axworthy DB, Mallett RW, Fritzberg AR, Theodore LJ, Plascjak PS, Eckelman WC, Waldmann TA, Pastan I, Paik CH, Brechbiel MW, Carrasquillo JA. Yao Z, et al. Among authors: pastan i. Clin Cancer Res. 2004 May 1;10(9):3137-46. doi: 10.1158/1078-0432.ccr-03-0171. Clin Cancer Res. 2004. PMID: 15131055

7

Mesothelin: a new target for immunotherapy.

Hassan R, Bera T, Pastan I. Hassan R, et al. Among authors: pastan i. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3937-42. doi: 10.1158/1078-0432.CCR-03-0801. Clin Cancer Res. 2004. PMID: 15217923 Review.

8

Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies.

Ise T, Maeda H, Santora K, Xiang L, Kreitman RJ, Pastan I, Nagata S. Ise T, et al. Among authors: pastan i. Clin Cancer Res. 2005 Jan 1;11(1):87-96. Clin Cancer Res. 2005. PMID: 15671532

9

HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicity.

Bang S, Nagata S, Onda M, Kreitman RJ, Pastan I. Bang S, et al. Among authors: pastan i. Clin Cancer Res. 2005 Feb 15;11(4):1545-50. doi: 10.1158/1078-0432.CCR-04-1939. Clin Cancer Res. 2005. PMID: 15746059

10

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.

Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Ho M, et al. Among authors: pastan i. Clin Cancer Res. 2005 May 15;11(10):3814-20. doi: 10.1158/1078-0432.CCR-04-2304. Clin Cancer Res. 2005. PMID: 15897581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,282 results

Search Page

Filters